The first pick would be in the pharma space, we are seeing quite good momentum here today, so pharma you can see Syngene which is giving you a good fresh breakout above 700 level so I think it is looking quite positive from current levels to test higher targets of 720, 725.
Will Ambani’s all-fresh Jio sale prove to be a masterstroke for investors?
Reliance Jio is set to roll out an ambitious Rs 30,213 crore IPO featuring solely new equity shares, not existing ones. In light of mixed